{
    "code": "01057998",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01057998",
    "time": "2023-11-09 19:18:41",
    "許可證字號": "衛署藥製字第057998號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "117\/07\/11",
    "發證\/登錄日期": "102\/07\/11",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00105799803",
    "中文品名": "&quot;晟德&quot;安立舒內服液劑",
    "英文品名": "ApraZ oral Solution &quot;CENTER&quot;",
    "適應症": "1.成人和青少年(13至17歲)的思覺失調症。\r\n2.治療小兒思覺失調症的特殊考量：兒童及青少年的精神疾患的診斷標準通常與成人不一致。建議於充分診斷及評估相關風險後再給予藥物治療。藥物治療小兒思覺失調症應僅是總體治療(包含心理、教育及社會介入)的一部分。\r\n3.成⼈和兒童(10⾄17歲)的雙極性疾患之躁症發作及混合型發作，可單獨使⽤或做為鋰鹽或Valproate的輔助治療。\r\n4.第⼀型雙極性疾患維持治療之鋰鹽或valproate的輔助治療。\r\n5.重鬱症之輔助治療。\r\n6.兒童(6⾄17歲)的⾃閉性疾患伴隨之急躁易怒。\r\n7.妥瑞氏症。",
    "劑型": "170內服液劑",
    "包裝": "4000毫升以下塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ARIPIPRAZOLE",
    "限制項目": "01國　產 26監視期滿新藥 61完成BE試驗",
    "申請商名稱": "晟德大藥廠股份有限公司",
    "申請商地址": "台北市南港區園區街3之2號7樓",
    "主製造廠": [
        {
            "製造廠名稱": "晟德大藥廠股份有限公司新竹廠",
            "製造廠廠址": "新竹縣湖口鄉實踐路2號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "晟德大藥廠股份有限公司",
            "製造廠廠址": "台北市南港區園區街3之2號7樓",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "主成分(drug substance)製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200095400",
            "成分名稱": "ARIPIPRAZOLE",
            "含量描述": "",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "01057998002-104-12-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057998&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "01057998001-106-05-11(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057998&Seq=036&Type=9"
        },
        {
            "title": "安立舒紙盒-E02-20190919 適應症變更-108-11-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057998&Seq=014&Type=8"
        },
        {
            "title": "安立舒150ml標籤-E02-20190917 適應症變更-108-11-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057998&Seq=013&Type=8"
        },
        {
            "title": "晟德安立舒內服液劑外盒-108-09-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057998&Seq=012&Type=8"
        },
        {
            "title": "晟德安立舒內服液劑標籤-108-09-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057998&Seq=011&Type=8"
        },
        {
            "title": "01057998004-104-12-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057998&Seq=010&Type=8"
        }
    ]
}